Gene · 3357
Papers2,210
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,210
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PDK4-dependent hypercatabolism and lactate production of senescent cells promotes cancer malignancy. | Nat Metab | 2023 | 37903887 | PubTator, text mining | PubMed |
| CYP1A2 expression rather than genotype is associated with olanzapine concentration in psychiatric patients. | Sci Rep | 2023 | 37898643 | PubTator, text mining | PubMed |
| RNA-Based Therapeutic Technology. | Int J Mol Sci | 2023 | 37894911 | PubTator, text mining | PubMed |
| Artificial Intelligence/Machine Learning-Driven Small Molecule Repurposing via Off-Target Prediction and Transcriptomics. | Toxics | 2023 | 37888725 | PubTator, text mining | PubMed |
| Rapid Synthesis of Psychoplastogenic Tropane Alkaloids. | JACS Au | 2023 | 37885569 | PubTator, text mining | PubMed |
| Cardiovascular safety of psychedelic medicine: current status and future directions. | Pharmacol Rep | 2023 | 37874530 | PubTator, text mining | PubMed |
| Treatment of acute-onset hypertension in pregnancy: A network meta-analysis of randomized controlled trials comparing anti-hypertensives and route of administration. | Pregnancy Hypertens | 2023 | 37857042 | PubTator, text mining | PubMed |
| Depletion of dopamine in Parkinson's disease and relevant therapeutic options: A review of the literature. | AIMS Neurosci | 2023 | 37841347 | PubTator, text mining | PubMed |
| Effects of (-)-MBP, a novel 5-HT2C agonist and 5-HT2A/2B antagonist/inverse agonist on brain activity: A phMRI study on awake mice. | Pharmacol Res Perspect | 2023 | 37837184 | PubTator, text mining | PubMed |
| Structural studies of serotonin receptor family. | BMB Rep | 2023 | 37817438 | PubTator, text mining | PubMed |
| TRAIL promotes the polarization of human macrophages toward a proinflammatory M1 phenotype and is associated with increased survival in cancer patients with high tumor macrophage content. | Front Immunol | 2023 | 37809073 | PubTator, text mining | PubMed |
| Identification of the bacterial metabolite aerugine as potential trigger of human dopaminergic neurodegeneration. | Environ Int | 2023 | 37797477 | PubTator, text mining | PubMed |
| L-DOPA-therapy in Parkinson's disease: some personal reflections on L-DOPA therapy from Vienna and Berlin. | J Neural Transm (Vienna) | 2023 | 37796288 | PubTator, text mining | PubMed |
| Integrative dissection of 5-hydroxytryptamine receptors-related signature in the prognosis and immune microenvironment of breast cancer. | Front Oncol | 2023 | 37795441 | PubTator, text mining | PubMed |
| Noteworthy perspectives on microglia in neuropsychiatric disorders. | J Neuroinflammation | 2023 | 37794488 | PubTator, text mining | PubMed |
| The First AAU International Conference on Pharmacy and Biomedical Sciences. | BMC Proc | 2023 | 37794446 | PubTator, text mining | PubMed |
| Reintroducing Fenfluramine as a Treatment for Seizures: Current Knowledge, Recommendations and Gaps in Understanding. | Neuropsychiatr Dis Treat | 2023 | 37790801 | PubTator, text mining | PubMed |
| Velusetrag rescues GI dysfunction, gut inflammation and dysbiosis in a mouse model of Parkinson's disease. | NPJ Parkinsons Dis | 2023 | 37783672 | PubTator, text mining | PubMed |
| Imidazoles as Serotonin Receptor Modulators for Treatment of Depression: Structural Insights and Structure-Activity Relationship Studies. | Pharmaceutics | 2023 | 37765177 | PubTator, text mining | PubMed |
| Synergistic Interaction of 5-HT1B and 5-HT2B Receptors in Cytoplasmic Ca2+ Regulation in Human Umbilical Vein Endothelial Cells: Possible Involvement in Pathologies. | Int J Mol Sci | 2023 | 37762136 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3357/papers?page=9